About Vimian
Vimian is a publicly listed company based in Stockholm (Sweden) founded in 2016. Innovative technology solutions for animal health improvement are provided. The company has 1,200 employees. Vimian has completed 4 acquisitions, including Bova, Kahuvet and Vet-Allergy. Its chief executive, as recorded, is Fredrik Ullman. Vimian offers products and services including Specialty Pharma and MedTech. Its focus areas include Services to Veterinary Health. Its legal entity is Vimian Group AB (publ).
Company details
Vimian was founded in 2016 and is headquartered in Stockholm, Sweden. Operations focus on the animal health sector, where technology solutions are developed and supplied to enhance veterinary practices and outcomes. Services include tools for diagnostics, treatment, and management in animal care. The company is led by CEO Fredrik Ullman, with activities centered in Europe.
- Headquarters Stockholm, Sweden
- Employees 1,200
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website vimian.com
- Social LinkedIn
- Legal Name Vimian Group Ab
- Annual Revenue$510.33 M (USD)9.75as on Dec 31, 2025
- Net Profit$37.62 M (USD)63.75as on Dec 31, 2025
- EBITDA$132.47 M (USD)13.36as on Dec 31, 2025
- Employee Count1,200
- Investments & AcquisitionsBova
& 3 more
Products & Services of Vimian
Vimian offers a comprehensive portfolio of products and services, including Specialty Pharma and MedTech.
Specialty pharmaceutical products are developed and distributed to support animal health in various markets.
MedTech solutions are provided for diagnostics and treatments, enabling better care for animals through innovative tools.
People of Vimian
3 people are tracked at Vimian (3 in leadership); the tracked headcount is 1,200.
| Name | Role | Group |
|---|---|---|
Fredrik Ullman | CEO | Leadership |
Ellen Broström | Sustainability (esg) Director | Leadership |
Pär Malmqvist | Head Of IT And Information Security | Leadership |
Complete people profiles for Vimian
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Vimian
Vimian is a publicly listed company on the OMXSTO with ticker symbol VIMIAN in Sweden, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date22 Aug 2022
- Listed onOTCMKTS: VIMGF
- Listed entityVimian Group AB
- Exchange sectorHealth technology
- ISINSE0015961982
- Share price37.10 SEK (+0.13% on the day) · 2026-10-14
- Market capitalisation19,536,694,803.00 SEK
- Price to earnings48.9
- EPS (diluted, trailing year)0.76 SEK
- Volume (last session)9,639
Financials of Vimian
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 4.70B SEK | 346.4M SEK | 1.22B SEK |
| 2024 | 4.29B SEK | 211.6M SEK | 1.08B SEK |
| 2023 | 3.81B SEK | 112.9M SEK | 963.5M SEK |
| 2022 | 2.99B SEK | -71.7M SEK | 859.6M SEK |
| 2021 | 1.76B SEK | 66.8M SEK | 562.3M SEK |
Detailed financial statements for Vimian
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vimian
Vimian has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Bova, Kahuvet and Vet-Allergy.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Veterinary consulting and coaching services are provided to professionals. | vettr.com.au | Brisbane, Australia | 2017 | Mar 2023 | •••• | |
Manufacturer of veterinary medicines and supplements | bova.co.uk | London, United Kingdom | 2008 | Mar 2022 | •••• | |
Veterinary clinic and lab services are provided in Denmark. | vet-allergy.com | Aalborg, Denmark | 2007 | Feb 2022 | •••• | |
Veterinary equipment is sold via an online medical store. | kahuvet.co.nz | Auckland, New Zealand | 2010 | Feb 2022 | •••• |
Complete acquisition details for Vimian
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Vimian
6 dated milestones of Vimian across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Vimian is founded.
- Acquisition Acquires Kahuvet.
- Acquisition Acquires Vet-Allergy.
- Acquisition Acquires Bova.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Vettr.
Web traffic of Vimian
The website of Vimian (vimian.com) receives about 7.7K visits a month.
- Monthly visits7.7K
▼ 19.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vimian
Complete news archive for Vimian
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vimian
Vimian was founded in 2016.
Vimian is headquartered in Stockholm, Sweden.
Fredrik Ullman is the CEO of Vimian, as recorded in our data.
Vimian has 1,200 employees.
Annual revenue of Vimian is $510.33M as on Dec 31, 2025.
Vimian was founded in 2016 and is headquartered in Stockholm, Sweden. Operations focus on the animal health sector, where technology solutions are developed and supplied to enhance veterinary practices and outcomes. Services include tools for diagnostics, treatment, and management in animal care. The company is led by CEO Fredrik Ullman, with activities centered in Europe.
Vimian offers Specialty Pharma and MedTech.
Yes, Vimian is publicly traded on OMXSTO under the ticker symbol VIMIAN.
Vimian has made 4 acquisitions, including Bova, Kahuvet, and Vet-Allergy.
Vimian operates through Vimian Group Ab (Publ).